Literature DB >> 2166428

Comparative clearance of quartz and cristobalite from the lung.

D R Hemenway1, M P Absher, L Trombley, P M Vacek.   

Abstract

The two silicon dioxide polymorphs, quartz and cristobalite, are known to have different toxicities. The clearance kinetics and biological response of two sources of quartz and one source of pure cristobalite were compared. Models were also developed to show the accumulation of cristobalite in the lungs of Fischer 344 rats as the result of short-term exposures at three different concentrations. The amount of cristobalite cleared from the lung was considerably less than that of the two quartz materials, with little or no clearance after the initial 30 days post exposure. As an indicator of the cellular biological response to the aerosols, total and differential cell counts were measured on bronchoalveolar lavage specimens. Cristobalite showed an early and sustained response with an elevated macrophage, neutrophil, and lymphocyte count through 180 days post exposure. The two quartz materials were not identical in their biological behavior even though they had identical crystal structure and similar trace element analysis. One quartz sample (MIN5) showed an increase in cell response (macrophage, neutrophils, and lymphocytes) approximately 30% that of cristobalite, whereas the other quartz material was not significantly different from control values. In addition, lung hydroxyproline content was greater in the cristobalite-exposed animals.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2166428     DOI: 10.1080/15298669091369790

Source DB:  PubMed          Journal:  Am Ind Hyg Assoc J        ISSN: 0002-8894


  9 in total

1.  In vitro toxicology of respirable Montserrat volcanic ash.

Authors:  M R Wilson; V Stone; R T Cullen; A Searl; R L Maynard; K Donaldson
Journal:  Occup Environ Med       Date:  2000-11       Impact factor: 4.402

2.  Assessment of the exposure of islanders to ash from the Soufriere Hills volcano, Montserrat, British West Indies.

Authors:  A Searl; A Nicholl; P J Baxter
Journal:  Occup Environ Med       Date:  2002-08       Impact factor: 4.402

3.  Relation between pulmonary clearance and particle burden: a Michaelis-Menten-like kinetic model.

Authors:  R C Yu; S M Rappaport
Journal:  Occup Environ Med       Date:  1996-08       Impact factor: 4.402

4.  Pulmonary epithelial response in the rat lung to instilled Montserrat respirable dusts and their major mineral components.

Authors:  D G Housley; K A Bérubé; T P Jones; S Anderson; F D Pooley; R J Richards
Journal:  Occup Environ Med       Date:  2002-07       Impact factor: 4.402

5.  Inhalation Exposure to Carbon Nanotubes (CNT) and Carbon Nanofibers (CNF): Methodology and Dosimetry.

Authors:  Günter Oberdörster; Vincent Castranova; Bahman Asgharian; Phil Sayre
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2015       Impact factor: 6.393

6.  Lung cancer incidence among Norwegian silicon carbide industry workers: associations with particulate exposure factors.

Authors:  Merete Drevvatne Bugge; Kristina Kjærheim; Solveig Føreland; Wijnand Eduard; Helge Kjuus
Journal:  Occup Environ Med       Date:  2012-05-18       Impact factor: 4.402

7.  The structure of volcanic cristobalite in relation to its toxicity; relevance for the variable crystalline silica hazard.

Authors:  Claire J Horwell; Benedict J Williamson; Ken Donaldson; Jennifer S Le Blond; David E Damby; Leon Bowen
Journal:  Part Fibre Toxicol       Date:  2012-11-19       Impact factor: 9.400

8.  Mortality from non-malignant respiratory diseases among workers in the Norwegian silicon carbide industry: associations with dust exposure.

Authors:  Merete Drevvatne Bugge; Solveig Føreland; Kristina Kjærheim; Wijnand Eduard; Jan Ivar Martinsen; Helge Kjuus
Journal:  Occup Environ Med       Date:  2011-03-01       Impact factor: 4.402

Review 9.  Surface reactivity in the pathogenic response to particulates.

Authors:  B Fubini
Journal:  Environ Health Perspect       Date:  1997-09       Impact factor: 9.031

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.